[
  {
    "ts": null,
    "headline": "McKesson Stock Gains 34.1% YTD: What's Driving the Rally?",
    "summary": "MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.",
    "url": "https://finnhub.io/api/news?id=1ca68826919701098a019dd50a262a646da66a361c886c0ca665b7e144dced9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732212300,
      "headline": "McKesson Stock Gains 34.1% YTD: What's Driving the Rally?",
      "id": 131555437,
      "image": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.",
      "url": "https://finnhub.io/api/news?id=1ca68826919701098a019dd50a262a646da66a361c886c0ca665b7e144dced9c"
    }
  },
  {
    "ts": null,
    "headline": "McKesson Corp. stock outperforms competitors on strong trading day",
    "summary": "McKesson Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8541fd9fb7e74b73cee35860c7745c36973a33a2fcd60f71e9fafa29b9c6035b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732207560,
      "headline": "McKesson Corp. stock outperforms competitors on strong trading day",
      "id": 131603490,
      "image": "",
      "related": "MCK",
      "source": "MarketWatch",
      "summary": "McKesson Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8541fd9fb7e74b73cee35860c7745c36973a33a2fcd60f71e9fafa29b9c6035b"
    }
  },
  {
    "ts": null,
    "headline": "MCK Stock Down Despite Latest Partnership to Boost SCD Treatment",
    "summary": "The availability of the FDA-approved drug via McKesson's cell and gene therapies business is expected to give patients improved treatment options for SCD.",
    "url": "https://finnhub.io/api/news?id=0538f09a24c5b38ced11cc84ff3a75a772e1058624264bc278d4e79fde9f3359",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732206480,
      "headline": "MCK Stock Down Despite Latest Partnership to Boost SCD Treatment",
      "id": 131555246,
      "image": "https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "The availability of the FDA-approved drug via McKesson's cell and gene therapies business is expected to give patients improved treatment options for SCD.",
      "url": "https://finnhub.io/api/news?id=0538f09a24c5b38ced11cc84ff3a75a772e1058624264bc278d4e79fde9f3359"
    }
  },
  {
    "ts": null,
    "headline": "McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 89% of the company",
    "summary": "Key Insights Significantly high institutional ownership implies McKesson's stock price is sensitive to their trading...",
    "url": "https://finnhub.io/api/news?id=139032b7c39e5468602a4960263e2650bccded6e2d169c332ea97bcf0dae3cc2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732197629,
      "headline": "McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 89% of the company",
      "id": 131541324,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/3dcac57ef5d9ab9e4cf0d2dc9ba3ef0b",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Key Insights Significantly high institutional ownership implies McKesson's stock price is sensitive to their trading...",
      "url": "https://finnhub.io/api/news?id=139032b7c39e5468602a4960263e2650bccded6e2d169c332ea97bcf0dae3cc2"
    }
  },
  {
    "ts": null,
    "headline": "McKesson (MCK) Price Target Increased by 10.57% to 658.09",
    "summary": "McKesson (MCK) Price Target Increased by 10.57% to 658.09",
    "url": "https://finnhub.io/api/news?id=2b26b3930c11619ca92a2757bcc1121ab98240123cc88bd3eee9c536fc211d27",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732152637,
      "headline": "McKesson (MCK) Price Target Increased by 10.57% to 658.09",
      "id": 131522149,
      "image": "",
      "related": "MCK",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=2b26b3930c11619ca92a2757bcc1121ab98240123cc88bd3eee9c536fc211d27"
    }
  }
]